Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expression |
| |
Authors: | Iris Barshack Eti Meiri Shai Rosenwald Danit Lebanony Meital Bronfeld Sarit Aviel-Ronen Kinneret Rosenblatt Sylvie Polak-Charcon Ilit Leizerman Meital Ezagouri Merav Zepeniuk Norberto Shabes Lahav Cohen Sarit Tabak Dalia Cohen Zvi Bentwich Nitzan Rosenfeld |
| |
Affiliation: | 1. Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini street, Cairo, Egypt;2. Analytical Chemistry Department, Faculty of Pharmacy, Egyptian Russian University, Badr City, Cairo, Egypt;3. Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt;4. Analytical Chemistry Department, Faculty of Pharmacy, Future University, Fifth Settlement, Cairo, Egypt;1. Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Beni-Suef University, Al shaheed Shehata Ahmed Hegazy st., 62514 Beni-Suef, Egypt;2. Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini st., 11562 Cairo, Egypt |
| |
Abstract: | Distinguishing hepatocellular carcinoma from metastatic tumors in the liver is of great practical importance, with significant therapeutic and prognostic implications. This differential diagnosis can be difficult because metastatic cancers in the liver, especially adenocarcinomas, may mimic the morphology and immunoexpression of hepatocellular carcinoma. Biomarkers that are specifically expressed in either hepatocellular carcinoma or metastatic adenocarcinoma can therefore be useful diagnostic tools. To find such biomarkers, we studied microRNA expression in 144 tumor samples using custom microarrays. Hsa-miR-141 and hsa-miR-200c, microRNAs that promote epithelial phenotypes, had significantly higher levels in non-hepatic epithelial tumors. In contrast, endothelial-associated hsa-miR-126 showed higher expression levels in hepatocellular carcinomas. Combinations of these microRNAs accurately identified primary hepatocellular carcinoma from metastatic adenocarcinoma in the liver. These findings were validated using quantitative real-time PCR to measure microRNA expression in additional samples. Thus, the tissue-specific expression patterns of microRNAs make them useful biomarkers for the diagnosis of liver malignancies. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|